LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, announced that it has surpassed 1,000 early-stage platform subscribers as it continues to advance its mobile healthcare application ecosystem for the Apple App Store and Google Play Store. The company is developing applications to support telehealth, healthcare communication, patient engagement, provider coordination, emergency response, and AI-assisted healthcare initiatives as part of a broader digital healthcare infrastructure strategy focused on emerging markets, particularly Latin America.
The milestone of 1,000 early subscribers reflects continued early interest and engagement with the LataMed AI healthcare technology ecosystem, according to management. The company believes that ongoing onboarding activity and user engagement may provide valuable operational feedback as development efforts progress and additional platform functionality is evaluated and refined.
Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: "We are continuing to advance development of our mobile healthcare application ecosystem with the goal of expanding accessibility and healthcare connectivity through both Apple and Android mobile platforms. Surpassing 1,000 early-stage users represents an encouraging milestone as we continue refining and expanding our broader digital healthcare infrastructure initiatives."
According to the company, certain applications are being prepared for anticipated future submission and availability through the Apple App Store and Google Play Store following continued development, internal testing, platform review processes, and applicable regulatory considerations. The applications and related platform technologies remain under active development and have not yet been fully commercialized or broadly deployed. No assurance can be provided regarding the timing of any public release, App Store or Google Play availability, regulatory progression, commercialization initiatives, future platform functionality, or operational success.
The company's broader technology initiatives remain focused on scalable healthcare infrastructure solutions intended to support underserved and developing markets where access to healthcare coordination, telehealth services, and digital healthcare tools may be limited or fragmented. This announcement is significant because it signals progress in bringing digital health tools to regions with constrained healthcare access, potentially improving patient outcomes and provider efficiency.
For more information, visit https://latamed.ai, follow the company’s official Instagram page at https://www.instagram.com/latamedai, or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
